Saturday, January 8, 2022

FDA grants IND clearance for REGENXBIO's gene therapy trial for Duchenne - Clinical Trials Arena

RGX-202 is a one-time gene therapy that leverages the NAV AAV8 vector of REGENXBIO. It will deliver a transgene for a new microdystrophin that ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...